Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Jubilant Pharmova Ltd.
NSE: JUBLPHARMA
|
BSE: 530019
|
ISIN: INE700A01033
|
Industry: Pharmaceuticals
Results
|
Mid-range Performer
1005.5500
-8.65
(
-0.85
%)
NSE
May 21, 2026
11:48 AM
27.92% Gain from 52W Low
Volume:
45,814
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Jubilant Pharmova Ltd.
03 Aug 2022
Results
1005.55
-0.85%
Jubilant Pharmova
Sell:
Jubilant Pharmova Ltd.
by
ICICI Direct
Target: 340
ICICI Direct
Jubilant Pharmova Ltd. is trading
above its 150 day SMA
of 993.0
More from Jubilant Pharmova Ltd.
Recommended
Market trades higher, Adtiya Birla Capital's board approves a Rs 4,000 crore preferential issue
Trendlyne Marketwatch |
21 May 2026, 11:13AM
Everyone's talking about the FII exodus, but there are stocks that they are buying
The Baseline |
20 May 2026, 06:54PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
|
30 May 2020